VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

B. anthracis PA protein Vaccine with TMDP
Vaccine Information
  • Vaccine Name: B. anthracis PA protein Vaccine with TMDP
  • Target Pathogen: Bacillus anthracis
  • Target Disease: Anthrax
  • Vaccine Ontology ID: VO_0004270
  • Type: Subunit vaccine
  • Status: Research
  • Antigen: B. anthracis PA protein (Ivins et al., 1992).
  • Adjuvant:
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Guinea pig Response

  • Host Strain: Hartley
  • Vaccination Protocol: Several adjuvant preparations combined with PA were compared with each other and with MDPH-PA with respect to protection and elicitation of anti-PA antibody. In the first experiment, guinea pigs received one or more injections of each preparation (Ivins et al., 1992).
  • Challenge Protocol: Guinea pigs were challenged i.m. 10 weeks after the first immunization with 7,300 (73 LD50) of B. anthracis Ames spores (Ivins et al., 1992).
  • Efficacy: 12/18 guinea pigs survived challenge after immunization with 1 dose of PA + TMDP and 13/20 survived after 2 doses of PA + TMDP (Ivins et al., 1992).
References
Ivins et al., 1992: Ivins BE, Welkos SL, Little SF, Crumrine MH, Nelson GO. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infection and immunity. 1992; 60(2); 662-668. [PubMed: 1730501].